Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 5,300 shares at $159.69 ($842K) on 2018-08-13, disclosed to the SEC on 2018-08-15.
Open-market sale of $842k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $157.62 | 730 | $115K | 13.7% |
| 2 | $158.66 | 3,070 | $487K | 57.9% |
| 3 | $159.69 | 1,500 | $240K | 28.5% |
| Total | $158.81 avg | 5,300 | $842K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $426K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |